Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 9 studies | 44% ± 21% | |
enterocyte | 8 studies | 47% ± 25% | |
hepatocyte | 5 studies | 73% ± 21% | |
adipocyte | 5 studies | 37% ± 8% | |
goblet cell | 4 studies | 22% ± 2% | |
epithelial cell | 4 studies | 36% ± 10% | |
kidney loop of Henle epithelial cell | 3 studies | 25% ± 8% | |
mature NK T cell | 3 studies | 25% ± 4% | |
renal alpha-intercalated cell | 3 studies | 31% ± 10% | |
progenitor cell | 3 studies | 40% ± 14% | |
cholangiocyte | 3 studies | 46% ± 24% | |
endothelial cell | 3 studies | 32% ± 13% | |
intestinal crypt stem cell | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 94940.50 | 226 / 226 | 87% | 257.17 | 355 / 406 |
kidney | 99% | 40476.53 | 88 / 89 | 72% | 60.44 | 652 / 901 |
intestine | 56% | 8524.67 | 537 / 966 | 68% | 22.99 | 357 / 527 |
adipose | 98% | 11632.08 | 1182 / 1204 | 0% | 0 | 0 / 0 |
breast | 76% | 7053.76 | 349 / 459 | 8% | 1.08 | 94 / 1118 |
ovary | 23% | 268.22 | 41 / 180 | 44% | 11.31 | 189 / 430 |
stomach | 4% | 157.12 | 13 / 359 | 59% | 15.95 | 168 / 286 |
bladder | 10% | 164.05 | 2 / 21 | 20% | 4.14 | 103 / 504 |
esophagus | 6% | 91.60 | 91 / 1445 | 22% | 7.68 | 41 / 183 |
pancreas | 2% | 9.71 | 5 / 328 | 22% | 5.62 | 40 / 178 |
blood vessel | 19% | 558.55 | 252 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 9% | 108.76 | 22 / 258 | 3% | 0.61 | 8 / 230 |
lung | 3% | 58.89 | 18 / 578 | 8% | 2.80 | 92 / 1155 |
thymus | 10% | 116.18 | 64 / 653 | 0% | 0.02 | 1 / 605 |
skin | 7% | 88.80 | 129 / 1809 | 1% | 0.32 | 7 / 472 |
uterus | 1% | 14.20 | 2 / 170 | 7% | 3.20 | 32 / 459 |
tonsil | 0% | 0 | 0 / 0 | 7% | 1.96 | 3 / 45 |
heart | 6% | 76.13 | 49 / 861 | 0% | 0 | 0 / 0 |
brain | 5% | 47.51 | 132 / 2642 | 0% | 0.05 | 2 / 705 |
prostate | 3% | 33.59 | 7 / 245 | 0% | 0.01 | 1 / 502 |
muscle | 2% | 16.58 | 16 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 23.56 | 13 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 79.42 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_1904628 | Biological process | cellular response to phorbol 13-acetate 12-myristate |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0046327 | Biological process | glycerol biosynthetic process from pyruvate |
GO_1904640 | Biological process | response to methionine |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0043382 | Biological process | positive regulation of memory T cell differentiation |
GO_0006107 | Biological process | oxaloacetate metabolic process |
GO_0032868 | Biological process | response to insulin |
GO_0051365 | Biological process | cellular response to potassium ion starvation |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0046890 | Biological process | regulation of lipid biosynthetic process |
GO_0014823 | Biological process | response to activity |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0042594 | Biological process | response to starvation |
GO_0097403 | Biological process | cellular response to raffinose |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0070741 | Biological process | response to interleukin-6 |
GO_0046166 | Biological process | glyceraldehyde-3-phosphate biosynthetic process |
GO_0071475 | Biological process | cellular hyperosmotic salinity response |
GO_0071320 | Biological process | cellular response to cAMP |
GO_0071477 | Biological process | cellular hypotonic salinity response |
GO_0006094 | Biological process | gluconeogenesis |
GO_0071377 | Biological process | cellular response to glucagon stimulus |
GO_0072350 | Biological process | tricarboxylic acid metabolic process |
GO_0070365 | Biological process | hepatocyte differentiation |
GO_0071332 | Biological process | cellular response to fructose stimulus |
GO_0006006 | Biological process | glucose metabolic process |
GO_0042593 | Biological process | glucose homeostasis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0019543 | Biological process | propionate catabolic process |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0019003 | Molecular function | GDP binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004613 | Molecular function | phosphoenolpyruvate carboxykinase (GTP) activity |
GO_0030145 | Molecular function | manganese ion binding |
GO_0005525 | Molecular function | GTP binding |
GO_0031406 | Molecular function | carboxylic acid binding |
GO_0106264 | Molecular function | protein serine kinase activity (using GTP as donor) |
Gene name | PCK1 |
Protein name | Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PEPCK-C) (EC 4.1.1.32) (Serine-protein kinase PCK1) (EC 2.7.11.-) |
Synonyms | PEPCK1 |
Description | FUNCTION: Cytosolic phosphoenolpyruvate carboxykinase that catalyzes the reversible decarboxylation and phosphorylation of oxaloacetate (OAA) and acts as the rate-limiting enzyme in gluconeogenesis . Regulates cataplerosis and anaplerosis, the processes that control the levels of metabolic intermediates in the citric acid cycle . At low glucose levels, it catalyzes the cataplerotic conversion of oxaloacetate to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle . At high glucose levels, it catalyzes the anaplerotic conversion of phosphoenolpyruvate to oxaloacetate . Acts as a regulator of formation and maintenance of memory CD8(+) T-cells: up-regulated in these cells, where it generates phosphoenolpyruvate, via gluconeogenesis (By similarity). The resultant phosphoenolpyruvate flows to glycogen and pentose phosphate pathway, which is essential for memory CD8(+) T-cells homeostasis (By similarity). In addition to the phosphoenolpyruvate carboxykinase activity, also acts as a protein kinase when phosphorylated at Ser-90: phosphorylation at Ser-90 by AKT1 reduces the binding affinity to oxaloacetate and promotes an atypical serine protein kinase activity using GTP as donor . The protein kinase activity regulates lipogenesis: upon phosphorylation at Ser-90, translocates to the endoplasmic reticulum and catalyzes phosphorylation of INSIG proteins (INSIG1 and INSIG2), thereby disrupting the interaction between INSIG proteins and SCAP and promoting nuclear translocation of SREBP proteins (SREBF1/SREBP1 or SREBF2/SREBP2) and subsequent transcription of downstream lipogenesis-related genes . . |
Accessions | P35558 ENST00000319441.6 [P35558-1] |